© 2022 MJH Life Sciences™ and Modern Retina. All rights reserved.
Cheryl Guttman Krader, BS, Pharm
Articles
Survey: Retina specialists see need for alternative treatments for macular edema associated with noninfectious uveitis
June 27, 2022
Article
Survey respondents point to a perceived gap in treatments for uveitic macular edema, document interest in suprachoroidal drug delivery.
Unraveling burdens of X-linked retinitis pigmentosa
January 11, 2022
Article
Recent literature review reveals dearth of data, highlights need for more research.
Addressing diabetic eye disease in senior patients
November 01, 2021
Article
Confronting issues unique to aging may lead to better outcomes.
FDA approves XIPERE injection for treatment of uveitic macular edema
October 26, 2021
Article
XIPERE, the first therapy utilizing the suprachoroidal space, demonstrates rapid efficacy, durable benefit, and favorable safety profile.
Ophthalmology Foundation zeroes in on mission
September 06, 2021
Article
Organization looks to improve global eye care through ophthalmic education.
The state of retina therapeutics, dissected by international panel
August 26, 2021
Article
Ophthalmologists face challenges of drug delivery for retinal diseases.
Dry AMD treatment facilitated by swept-source OCT imaging
August 23, 2021
Article
Option detects treatment-naive nonexudative macular neovascularization in eyes with dry age-related macular degeneration.
Retina specialists may get ophthalmic formulation of bevacizumab
August 03, 2021
Article
FDA will be asked to consider ONS-5010 for treating wet AMD.
Gaining a greater understanding of AMD
July 21, 2021
Article
Why investigators are considering AMD to be a disease spectrum rather than a single disease.
Combining SD-OCT and UWF improves macular pathology detection
July 20, 2021
Article
Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.